Rebamipide
| CAS No. | 111911-87-6 | Cat. No. | BCP12128 |
| Name | Rebamipide | ||
| Synonyms | OPC12759;OPC 12759;OPC-12759;Proamipide; | ||
| Formula | C19H15ClN2O4 | M. Wt | 370.79 |
| Description | Rebamipide is a quinolinone derivative with anti-ulcer and anti-inflammatory activities. Rebamipide induces cyclooxygenase 2 (COX2) synthesis which results in an increase in endogenous prostaglandin synthesis in the gastric mucosa. This agent also inhibits H. pylori-induced production of tumor necrosis factor (TNF) alpha and subsequent inflammation of the gastric mucosa. In addition, rebamipide scavenges oxygen-derived free radicals that potentially cause mucosal injury, and stimulates prostaglandin EP4 receptor gene expression followed by mucous secretion, thereby enhancing the gastric mucosal defense. | ||
| Pathways | Neuro Signaling Pathway GPCR/G Protein | ||
| Targets | Prostaglandin Receptor COX | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.